Skip to content
Search

Latest Stories

Submit Guest Post

UK watchdog bans adverts claiming to cure ADHD and autism in children

Advertising Standards Authority cracks down on 'unacceptable' supplement promotions targeting vulnerable families

ADHD autism ad ban UK

Approved treatments exist to help manage ADHD symptoms through the NHS

Representative image - iStock

Highlights

  • ASA bans misleading adverts promising to cure autism and ADHD in children through food supplements.
  • EllaOla Facebook promotion claimed supplements lead to "fewer meltdowns" and children "trying NEW foods".
  • Over 500,000 people waiting for ADHD assessment in England, driving demand for unproven treatments.

Adverts for food supplements falsely claiming to cure autism and ADHD in children have been banned by Britain's advertising watchdog.

The Advertising Standards Authority (ASA) criticised the "unacceptable" online promotions as part of a sweeping crackdown on supplements claiming to treat neurodivergent conditions.


One Facebook promotion by EllaOla promised parents of autistic children that supplements could lead to "fewer meltdowns", "more energy & alertness" and even "trying NEW foods".

Israeli-based nutrition clinic Customized Autism Treatment claimed, "Autism Recovery Supplement" pills would treat ADHD symptoms, while UK brand Get Dopa said the phrase "the perfect gift for anyone with ADHD" came from an external customer review and the advert using the review was withdrawn after concerns were raised.

Get Dopa said its advert did not claim that its product improves clarity, focus, or energy for ADHD was not directed towards children. The ASA ruling on Get Dopa involved an implied medical claim created by a customer testimonial referencing ADHD, which appeared alongside general, authorised nutrition claims

The ASA said such adverts risked "misleading vulnerable people or steering those who need it away from appropriate medical advice".

Expert warnings escalate

Henry Shelford, co-founder of ADHD UK, said the charity was "constantly having to stop whatever is today's 'magical' supplement being promoted as an ADHD cure", as people wait for NHS appointments.

Jolanta Lasota, chief executive of Ambitious about Autism, warned parents of autistic children faced "online scammers offering fake cures that could in fact be incredibly harmful".

"There is no cure for autism, but we've seen dangerous social media adverts targeting online autism communities with bogus treatments, including edible psychedelics and bleach," she told The Telegraph.

Neither autism nor ADHD can be cured, though approved treatments exist to help manage ADHD symptoms through the NHS.
Long NHS waiting lists are driving demand for alternative treatments.

October figures showed over 500,000 people waiting for ADHD assessment in England. At current rates, ADHD UK claimed clearing the backlog would take 2,000 years.

Autism and ADHD are both forms of neurodivergence with overlapping traits and can often occur together. Get Dopa responded it intended to promote products as food supplements, not medical treatments, believing its claims were "general health claims".

Customized Autism Treatment said its advert was not intentionally created and may have appeared through automated online programmes, pledging preventive action.

EllaOla confirmed it had removed the advertisement and would not use it again.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cancer treatment

The NHS availability announced in September 2026 applies to eligible patients in England. The treatment has already been available in Scotland for more than two years.

What is Enhertu and how could the new NHS breast cancer treatment help patients?

Highlights:
  • Enhertu is a targeted treatment for certain HER2-low breast cancers.
  • It is available for around 1,000 women in England.
  • The drug can extend survival compared with chemotherapy.
  • NICE initially rejected widespread NHS use in 2024.
  • The decision was reversed after a commercial agreement was reached.

Breast cancer treatment continues to evolve as researchers develop therapies aimed at specific characteristics of cancer cells. One such treatment is Enhertu, which has now become available on the NHS in England for people with a particular type of advanced breast cancer.

The treatment is intended for patients with HER2-low breast cancer that cannot be removed through surgery or has spread to other parts of the body. This is known as metastatic breast cancer. According to the latest announcement, around 1,000 women in England will be eligible for the treatment.

Keep ReadingShow less